80
Participants
Start Date
September 30, 2009
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
Lidoderm 5 % Topical Patch
Patients will receive Lidoderm topical 5% lidocaine patches. Those will be placed to affected area up to three patches as needed for pain 12 hours on and 12 hours off
Placebo patch
2\) Group II: Patients will receive placebo patches. Those will be placed to affected area at dose up to three patches as needed for pain 12 hours on and 12 hours off
Cleveland Clinic, Cleveland
Collaborators (1)
Endo Pharmaceuticals
INDUSTRY
The Cleveland Clinic
OTHER